Close

Regeneron (REGN) Phase 3 Trial of Libtayo® Stopped Early Due to Significant Improvement in Overall Survival

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. CMG
4. LRCX
5. MSFT
6. IBM
7. SPY
8. INTC
9. SNAP
10. BA


Go back to Regeneron (REGN) Phase 3 Trial of Libtayo® Stopped Early Due to Significant Improvement in Overall Survival
Regeneron (NASDAQ: REGN) Delayed: 890.68 --0 (-0%)
Previous Close $890.68    52 Week High $592.36 
Open $890.68    52 Week Low $325.35 
Day High $890.68    P/E 233.77 
Day Low $890.68    EPS $3.81 
Volume 1